CME
CME Group Inc
268.90$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.0% | 72.6% | 60.0% | 50.7% | 63.3% | 66.7% | 68.0% | 62.6% | 63.0% | 68.8% | 67.0% | 55.5% | 63.6% | |
| 6.6% | 6.0% | 5.7% | 5.5% | 5.3% | 5.5% | 5.0% | 4.9% | 5.4% | 5.0% | 4.4% | 4.9% | 4.9% | |
| 1.4% | 1.7% | 1.6% | 1.2% | 1.3% | 1.8% | 1.3% | 1.2% | 1.6% | 1.8% | 1.2% | 1.5% | 1.5% | |
| 2.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.8% | 11.7% | -4.1% | -12.6% | -1.2% | 4.4% | 3.7% | -3.1% | -0.9% | 6.3% | 7.5% | -12.8% | 0.2% | |
| 1.5% | 1.4% | 1.3% | 1.2% | 1.9% | 1.7% | 0.9% | 1.1% | 1.2% | 2.0% | 1.2% | 1.4% | 1.4% | |
| -1.5% | -1.4% | -1.5% | -0.3% | -1.9% | -1.7% | -1.0% | -1.1% | -1.2% | 94.1% | -1.2% | -1.7% | 21.9% | |
| 29.9% | 27.8% | 156.5% | 27.3% | 26.4% | 27.5% | 156.3% | 26.9% | 29.6% | 27.6% | 143.5% | 27.4% | 60.2% | |
| -1.3% | -0.2% | -0.8% | 0.0% | -1.1% | -0.2% | -0.5% | -0.5% | -1.4% | -15.6% | -28.7% | -40.9% | -22.4% | |
| -1,947.2% | – | – | – | 0.0% | 0.0% | -0.5% | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -1,978.4% | 179.8% | 130.1% | -601.8% | 842.4% | -64.5% | 1,169.8% | 1,241.1% | 416.2% | 600.4% | 112.6% | -474.2% | 152.4% | |
| -1,915.8% | 42.5% | 188.6% | 23.0% | 903.8% | 0.6% | 1,236.8% | 1,302.6% | 477.9% | 763.3% | 178.4% | -420.4% | 237.9% | |
| 62.6% | 71.1% | 58.7% | 49.5% | 61.4% | 65.0% | 67.1% | 61.5% | 61.8% | 66.8% | 65.9% | 54.1% | 62.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.